FDA-Inspected Site

Abbott Laboratories Inc.

21 FDA inspections are on record for Abbott Laboratories Inc. in Casa Grande, United States.

483· Form 483 issued

Casa Grande, United States · Last updated July 9, 2026

Overview

  • 21 FDA inspections are on record.
  • 4 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-05-13.

At a glance

Inspections

21

Form 483s

4

EIRs

2

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
20 Apr 2026 – 13 May 2026Foods & Cosmetics483On file
2 Dec 2024 – 10 Jan 2025Foods & Cosmetics483View 483 →
12 Feb 2024 – 29 Mar 2024Foods & Cosmetics483View 483 →
4 Apr 2023 – 2 May 2023Foods & Cosmetics483View 483 →
31 Oct 2022 – 8 Nov 2022Foods & CosmeticsClean
20 Apr 2022 – 13 May 2022Foods & CosmeticsClean
16 Nov 2021 – 23 Nov 2021Foods & CosmeticsClean
15 Jul 2019 – 19 Jul 2019Foods & CosmeticsClean
5 Jun 2018 – 19 Jun 2018Foods & CosmeticsClean
20 Jun 2017 – 29 Jun 2017Foods & CosmeticsClean
13 Jul 2016 – 20 Jul 2016Foods & CosmeticsClean
1 Sep 2015 – 11 Sep 2015Foods & CosmeticsClean

Observations on record

Form 483 observations cited at this site, most recent first.

10 Jan 2025
21 CFR 106.20(a)

Maintain building in clean, sanitary condition

Cited by Danny Tuntevski, Desiree C Iya, Jennifer S King, Howard A Webley, Ciara J Bajulai Austin, Patricia P Wrona, Matthew R Miranda, Lauren D Kraemer

29 Mar 2024
21 CFR 106.20(a)

Maintain building in clean, sanitary condition

Cited by Amy L Mcintyre, Karen M Labounty, Kawshalya Pathiraja, Jennifer A Robinson, Eric R Holm, Nora W Kabbara, Ciara J Bajulai Austin, Patricia P Wrona

29 Mar 2024
21 CFR 106.50(e)

Controls, adulteration - monitored, alert

Cited by Amy L Mcintyre, Karen M Labounty, Kawshalya Pathiraja, Jennifer A Robinson, Eric R Holm, Nora W Kabbara, Ciara J Bajulai Austin, Patricia P Wrona

29 Mar 2024
21 CFR 106.55(a)

System of process controls to prevent adulteration

Cited by Amy L Mcintyre, Karen M Labounty, Kawshalya Pathiraja, Jennifer A Robinson, Eric R Holm, Nora W Kabbara, Ciara J Bajulai Austin, Patricia P Wrona

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 106.20(a)Cited across public-safe Form 483 observations2x
21 CFR 106.55(a)Cited across public-safe Form 483 observations2x
21 CFR 106.30(b)Cited across public-safe Form 483 observations1x
21 CFR 106.50(e)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Abbott Laboratories Inc.'s 4 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat